Skip to main content
Log in

Antineoplastics

Lack of efficacy in approved and unapproved indications: 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Paszkan E, et al. Rare case reports on thymic carcinoma patients treated with pembrolizumab. Journal for ImmunoTherapy of Cancer 8 (Suppl. 3): A465 abstr. 775, Nov 2020. Available from: URL: http://doi.org/10.1136/jitc-2020-SITC2020.0775 [abstract]

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antineoplastics. Reactions Weekly 1858, 41 (2021). https://doi.org/10.1007/s40278-021-96759-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-96759-1

Navigation